http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2519510-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c3c00ccdd91b56ddc9a6ee5d7b2e340
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14
filingDate 2010-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a888fca667c3f43171a8c0dca37b09a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d733db51f8a5f3b648a2e32106a5b8d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f6b760b5ec158022e8ca830e852c7cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3ae4f5a730c057d9085700e2f2c4d8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acc9fbf2b749124bac64709487780a10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a03f708524e3ce8176c3ac9d079030e
publicationDate 2012-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2519510-A2
titleOfInvention Method for preparing highly pure anhydrous crystalline docetaxel
abstract A method for preparing highly pure anhydrous crystalline docetaxel is provided. The method for preparing highly pure anhydrous crystalline docetaxel enables preparation of anhydrous crystalline docetaxel that has purity of 99.5% or more, and is useful as an anticancer agent due to remarkably low residual solvent content compared to the standard of residual solvents in drugs.
priorityDate 2009-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008200700-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008123751-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226486946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54277830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21880519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64780
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID25629
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID25629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396419
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID346948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID346948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226478747

Total number of triples: 36.